Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014626-13
Application #
3961663
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Rahman, A; Roh, J K; Wolpert-DeFilippes, M K et al. (1988) Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue. Cancer Res 48:1745-52
Rahman, A; Carmichael, D; Harris, M et al. (1986) Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes. Cancer Res 46:2295-9
Rahman, A; Fumagalli, A; Barbieri, B et al. (1986) Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes. Cancer Chemother Pharmacol 16:22-7
Rahman, A; Ganjei, A; Neefe, J R (1986) Comparative immunotoxicity of free doxorubicin and doxorubicin encapsulated in cardiolipin liposomes. Cancer Chemother Pharmacol 16:28-34
Rahman, A; Joher, A; Neefe, J R (1986) Immunotoxicity of multiple dosing regimens of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes. Br J Cancer 54:401-8
Law, J; Fumagalli, A; Schein, P S et al. (1985) Selective inhibition of cardiac cyclic nucleotide phosphodiesterases by doxorubicin and daunorubicin. Life Sci 36:589-99
Neefe, J R; Sullivan, J E; Ayoob, M et al. (1985) Augmented immunity in cancer patients treated with alpha-interferon. Cancer Res 45:874-8
Rahman, A; White, G; More, N et al. (1985) Pharmacological, toxicological, and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes. Cancer Res 45:796-803
Underhill, C B; Thurn, A L; Lacy, B E (1985) Characterization and identification of the hyaluronate binding site from membranes of SV-3T3 cells. J Biol Chem 260:8128-33